Nuclear receptors are hormone-gated transcription factors that couple metabolic and environmental signals to transcriptional outputs. We show that the C. elegans nuclear receptor NHR-8, a conserved homologue of mammalian Liver-X and Vitamin-D receptors, regulates the choice between reproductive development and arrest at the long-lived dauer diapause stage in response to available cholesterol. NHR-8 promotes production of dafachronic acids (DA), the bile acid ligands of the DAF-12 nuclear receptor, which govern the dauer decision. Loss of
nhr-8 results in misregulation of endogenous cholesterol levels and related metabolites, including reduced levels of both 7-dehydrocholesterol and DA. These phenotypes arise in part from reduced expression of the
daf-36 Rieske oxygenase, which carries out the first step in DA biosynthesis, converting dietary cholesterol to 7-dehydrocholesterol. Transcriptome analysis reveals that
nhr-8 regulates genes enriched in fatty-acid metabolism, oxidation-reduction, proteolysis, defense response, and determinants of lifespan. In particular, expression of the D9- and D12-fatty acid desaturases (
fat-5,
fat-7, and
fat-2) is downregulated in
nhr-8 mutants, resulting in reduced polyunsaturated fatty acid (PUFA) production. Cholesterol supplementation rescues various
nhr-8 phenotypes, including developmental arrest, unsaturated fatty acid deficiency, reduced fertility, and shortened lifespan, suggesting that
nhr-8 alters cholesterol deposition or transport.
nhr-8 also interacts with
daf-16/FOXO to regulate steady-state cholesterol levels, and is lethal when mutated in combination with insulin signaling mutants that promote excess growth, revealing a novel connection between insulin signaling and sterol metabolism. Similar to its mammalian counterpart LXR, our data define NHR-8 as an important regulator of cholesterol, bile acid, and fatty acid homeostasis, which ultimately modulates C. elegans reproduction, development, and lifespan.